...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Exempt Distribution
Reply New Message
Prev Message Back To Forum Threaded View Next Message

The only thing i can think of is DM may have pending deal close in  hand since Zenith E is private he can reveal more details to potential investors.....  I doubt it though,  

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply